Literature DB >> 7507186

Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.

K Takeuchi1, R A Lamb.   

Abstract

The influenza A/fowl plague virus/Rostock/34 hemagglutinin (HA), which is cleaved intracellularly and has a high pH threshold (pH 5.9) for undergoing its conformational change to the low-pH form, was expressed from cDNA in CV-1 and HeLa T4 cells in the absence of other influenza virus proteins. It was found, by biochemical assays, that the majority of the HA molecules were in a form indistinguishable from the low-pH form of HA. The acidotropic agent, ammonium chloride, stabilized the accumulation of HA in its native form. Coexpression of HA and the homotypic influenza virus M2 protein, which has ion channel activity, stabilized the accumulation of HA in its pH neutral (native) form, and the M2 protein ion channel blocker, amantadine, prevented the rescue of HA in its native form. These data provide direct evidence that the influenza virus M2 protein ion channel activity can affect the status of the conformational form of cleaved HA during intracellular transport.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507186      PMCID: PMC236528     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

3.  Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor.

Authors:  R G Paterson; R A Lamb
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

4.  Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.

Authors:  M Ohuchi; A Cramer; M Vey; R Ohuchi; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin.

Authors:  P C Roberts; W Garten; H D Klenk
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits.

Authors:  J Lazarovits; M Roth
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

7.  On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.

Authors:  J J Skehel; A J Hay; J A Armstrong
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

8.  The specific inhibition of influenza A virus maturation by amantadine: an electron microscopic examination.

Authors:  R W Ruigrok; E M Hirst; A J Hay
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

9.  Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector.

Authors:  K Kuroda; C Hauser; R Rott; H D Klenk; W Doerfler
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

10.  The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway.

Authors:  F Boulay; R W Doms; I Wilson; A Helenius
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  64 in total

Review 1.  Reverse genetics of negative-strand RNA viruses: closing the circle.

Authors:  A Pekosz; B He; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient.

Authors:  K Takeuchi; N Miyajima; F Kobune; M Tashiro
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

4.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity.

Authors:  Jun Hu; Riqiang Fu; Katsuyuki Nishimura; Li Zhang; Huan-Xiang Zhou; David D Busath; Viksita Vijayvergiya; Timothy A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

7.  Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host.

Authors:  Ruth Harvey; Andrew C R Martin; Maria Zambon; Wendy S Barclay
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Assembly of the m2 tetramer is strongly modulated by lipid chain length.

Authors:  Sandra Schick; Lirong Chen; Edwin Li; Janice Lin; Ingo Köper; Kalina Hristova
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

9.  Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein.

Authors:  Shinji Watanabe; Masaki Imai; Yoshiro Ohara; Takato Odagiri
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.

Authors:  Tokiko Watanabe; Shinji Watanabe; Takeshi Noda; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.